ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $145,000 | -6.5% | 10,200 | 0.0% | 0.04% | +5.4% |
| Q3 2018 | $155,000 | -9.4% | 10,200 | 0.0% | 0.04% | -19.6% |
| Q2 2018 | $171,000 | +3.0% | 10,200 | 0.0% | 0.05% | +2.2% |
| Q1 2018 | $166,000 | -8.8% | 10,200 | -28.2% | 0.04% | -10.0% |
| Q4 2017 | $182,000 | +4.0% | 14,200 | 0.0% | 0.05% | 0.0% |
| Q3 2017 | $175,000 | +47.1% | 14,200 | 0.0% | 0.05% | +38.9% |
| Q2 2017 | $119,000 | -6.3% | 14,200 | 0.0% | 0.04% | -10.0% |
| Q1 2017 | $127,000 | -57.8% | 14,200 | -58.5% | 0.04% | -58.8% |
| Q4 2016 | $301,000 | +19.9% | 34,200 | -8.1% | 0.10% | +14.1% |
| Q3 2016 | $251,000 | +90.2% | 37,200 | 0.0% | 0.08% | +84.8% |
| Q2 2016 | $132,000 | -11.4% | 37,200 | +5.7% | 0.05% | -16.4% |
| Q4 2015 | $149,000 | -41.3% | 35,200 | 0.0% | 0.06% | -40.9% |
| Q3 2015 | $254,000 | 0.0% | 35,200 | 0.0% | 0.09% | 0.0% |
| Q2 2015 | $254,000 | -1.9% | 35,200 | 0.0% | 0.09% | -1.1% |
| Q1 2015 | $259,000 | +21.0% | 35,200 | -22.1% | 0.09% | +22.1% |
| Q4 2014 | $214,000 | +127.7% | 45,200 | +72.5% | 0.08% | +108.1% |
| Q3 2014 | $94,000 | -21.0% | 26,200 | 0.0% | 0.04% | -24.5% |
| Q2 2014 | $119,000 | +20.2% | 26,200 | +24.8% | 0.05% | +8.9% |
| Q1 2014 | $99,000 | -5.7% | 21,000 | 0.0% | 0.04% | -8.2% |
| Q4 2013 | $105,000 | -19.8% | 21,000 | 0.0% | 0.05% | -31.9% |
| Q3 2013 | $131,000 | +37.9% | 21,000 | 0.0% | 0.07% | +24.1% |
| Q2 2013 | $95,000 | – | 21,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |